Aidoc vs Gleamer
A platform against a specialist, and both are strong records. Aidoc runs detection models across an imaging estate through an operating system that handles normalisation, continuous monitoring and governance, with a 2026 clearance covering many acute indications from one named foundation model. Gleamer does trauma radiography, with a fracture detection clearance covering adult and paediatric use that is reported to be unique in that segment and one of the deepest evidence bases in musculoskeletal imaging. If your department needs one specific reading improved, particularly the overnight trauma queue, Gleamer is the sharper instrument and reaches you through several platforms. If you expect to run clinical AI across modalities for a decade, Aidoc is selling the layer that survives whichever algorithms you replace.
- It runs many detection models across an imaging estate through an operating system handling normalisation, monitoring and governance for every model on it.
- The 2026 clearance covers a double digit set of acute indications from a single named foundation model, with performance from a regulator reviewed pivotal study.
- For a health system standardising clinical AI across modalities, the infrastructure is the durable purchase rather than any one algorithm.
- Its fracture detection clearance covers both adult and paediatric use, reported to be unique in that segment, with a clearance study design stronger than most here.
- The evidence base is one of the deepest in musculoskeletal imaging, and trauma radiography is the highest volume plain film reading in any emergency department.
- Distribution breadth substitutes for integration engineering, available directly and through several imaging platform partners.
Side by Side
| Axis | A Aidoc |
G Gleamer |
|---|---|---|
| AI Centrality | ||
| Autonomy and Oversight Model | ||
| Model and Technology Transparency | ||
| Clinical and Operational Evidence | ||
| AI Safety and PHI Stewardship | ||
| HIPAA and BAA Posture | ||
| Security Certifications and Trust Center | ||
| FDA and Regulatory Status | ||
| AI Governance and Bias Disclosure | ||
| EHR and Interoperability Depth | ||
| Deployment Model and Data Residency | ||
| Commercial Transparency | ||
| Setting and Specialty Coverage |
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Clinical Decision Support page.
The comparison is between a platform and a point solution, so the honest question is whether you are buying infrastructure or a specific reading. Gleamer's multi party distribution model makes data stewardship harder to answer, since no business associate terms were located and the responsible party varies by delivery path, and it publishes no security attestation, which this index records as a pattern across non United States imaging vendors rather than a fault unique to it. Neither publishes a subgroup performance analysis, and prevalence in your own population determines the false positive burden more than published sensitivity does.